Reading is good for you...
Reading about what's good for you is even better.
August 8, 2022
August 10, 2022
August 2, 2022
Get your Taro Letrozole delivered at your door for FREE
Letrozole belongs to the group of cancer-fighting medications known as antineoplastics, and specifically to the type of antineoplastics known as nonsteroidal aromatase inhibitor. Letrozole can be used after surgery to treat postmenopausal women with hormone receptor-positive early Breast Cancer, including those who have received approximately 5 years of Tamoxifen therapy.
We accept all insurance plans
**Actual price will depend on the insurance coverage in your province
Letrozole belongs to the group of cancer-fighting medications known as antineoplastics, and specifically to the type of antineoplastics known as nonsteroidal aromatase inhibitor.
Letrozole can be used after surgery to treat postmenopausal women with hormone receptor-positive early Breast Cancer, including those who have received approximately 5 years of Tamoxifen therapy. Letrozole can also be used to treat postmenopausal women with advanced breast cancer. It can also be used to treat women who have gone through natural or artificially induced Menopause who have breast cancer that has spread to other parts of the body and whose cancer has progressed following anti-estrogen therapy.
Letrozole fights breast cancer by inactivating an enzyme known as aromatase. This prevents the enzyme from supplying the estrogen that allows certain types of breast cancers to grow and survive.
Taro Letrozole may be available under multiple brand names and/or in several different forms. Any specific brand name of Taro Letrozole may not be available in all of the forms or approved for all of the conditions discussed here. As well, some forms of Taro Letrozole may not be used for all of the conditions discussed here.
Your doctor may have suggested Taro Letrozole for conditions other than those listed in these drug information articles. If you have not discussed this with your doctor or are not sure why you are taking Taro Letrozole, speak to your doctor. Do not stop taking Taro Letrozole without consulting your doctor.
Do not give Taro Letrozole to anyone else, even if they have the same symptoms as you do. It can be harmful for people to take Taro Letrozole if their doctor has not prescribed it.
The recommended dose of letrozole is 2.5 mg once daily. It should be taken at the same time each day and may be taken with or without food.
Many things can affect the dose of medication that a person needs, such as body weight, other medical conditions, and other medications. If your doctor has recommended a dose different from the ones listed here, do not change the way that you are taking the medication without consulting your doctor.
It is important to take Taro Letrozole exactly as prescribed by your doctor. If you miss a dose, take it as soon as possible and continue with your regular schedule. If it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one. If you are not sure what to do after missing a dose, contact your doctor or pharmacist for advice.
Store the tablets in a dry place at room temperature, out of reach of children and pets.
Do not dispose of medications in wastewater (e.g. down the sink or in the toilet) or in household garbage. Ask your pharmacist how to dispose of medications that are no longer needed or have expired.
Many medications can cause side effects. A side effect is an unwanted response to a medication when it is taken in normal doses. Side effects can be mild or severe, temporary or permanent.
The side effects listed below are not experienced by everyone who takes Taro Letrozole. If you are concerned about side effects, discuss the risks and benefits of Taro Letrozole with your doctor.
The following side effects have been reported by at least 1% of people taking Taro Letrozole. Many of these side effects can be managed, and some may go away on their own over time.
Contact your doctor if you experience these side effects and they are severe or bothersome. Your pharmacist may be able to advise you on managing side effects.
Although most of the side effects listed below don't happen very often, they could lead to serious problems if you do not seek medical attention.
Check with your doctor as soon as possible if any of the following side effects occur:
Stop taking the medication and seek immediate medical attention if any of the following occur:
Some people may experience side effects other than those listed. Check with your doctor if you notice any symptom that worries you while you are taking Taro Letrozole.
Each yellow, round, film-coated tablet, debossed with "RAN" on one side and "L2.5" on the other, contains 2.5 mg of letrozole. Nonmedicinal ingredients: colloidal silicon dioxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, opadry yellow (hypromellose, titanium dioxide, ferric oxide yellow, polyethylene glycol 8000, and talc), pregelatinized starch, and sodium starch glycolate.
There may be an interaction between letrozole and any of the following:
If you are taking any of these medications, speak with your doctor or pharmacist. Depending on your specific circumstances, your doctor may want you to:
An interaction between two medications does not always mean that you must stop taking one of them. Speak to your doctor about how any drug interactions are being managed or should be managed.
Medications other than those listed above may interact with Taro Letrozole. Tell your doctor or prescriber about all prescription, over-the-counter (non-prescription), and herbal medications that you are taking. Also tell them about any supplements you take. Since caffeine, alcohol, the Nicotine from cigarettes, or street drugs can affect the action of many medications, you should let your prescriber know if you use them.
Before you begin taking a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should take Taro Letrozole.
Blood Clots: Letrozole may cause an increase in the formation of blood clots in blood vessels, reducing the blood flow to organs or the extremities. In the arms or legs this is experienced as pain, swelling, warmth, or redness in the limb. In the lungs, you may experience difficulty breathing, sharp chest pain, coughing, or coughing up blood. If you experience any of these symptoms, contact your doctor immediately.
Bone mineral density: Long-term use of letrozole may decrease the density of bones, thereby increasing the risk of Osteoporosis. Your doctor will order bone mineral density tests periodically while you are taking letrozole.
Cholesterol: Letrozole may increase cholesterol levels. If you have increased blood cholesterol levels or a history of increased cholesterol, discuss with your doctor how Taro Letrozole may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Taro Letrozole, and whether any special monitoring is needed.
Drowsiness/dizziness: Letrozole may cause dizziness or drowsiness. If you experience either or both of these side effects, you should not drive, use machinery, or perform any other activities that require alertness.
Heart disease: Taro Letrozole may increase the risk of heart attack or increased blood pressure. If you are at risk for heart disease or high blood pressure, discuss with your doctor how Taro Letrozole may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Taro Letrozole, and whether any special monitoring is needed. If you experience signs of a heart attack, such as tightness or heaviness in your chest, sudden chest pain spreading to your arms or shoulders, sweating, nausea, or anxiety, seek medical help immediately.
Kidney function: If you have reduced kidney function, discuss with your doctor how Taro Letrozole may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Taro Letrozole, and whether any special monitoring is needed.
Liver function: If you have liver disease or reduced liver function, discuss with your doctor how Taro Letrozole may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Taro Letrozole, and whether any special monitoring is needed.
Premenopausal women: Letrozole should not be taken by women who have not reached menopause (either naturally or surgically), unless the potential benefits outweigh the risks.
Stroke: Taro Letrozole increases the risk of a stroke or "mini-strokes" occurring as a result of blood clots forming in the blood vessels. If you experience signs of a stroke or mini-stroke, such as confusion, difficulty speaking, loss of coordination, sudden headache or vision changes, contact your doctor immediately.
Pregnancy: It is suspected that the use of letrozole during pregnancy could cause miscarriages and other serious problems. It is not intended to be taken by women who have not reached menopause.
Taro Letrozole should not be taken during pregnancy unless the benefits outweigh the risks. Any woman taking Taro Letrozole who may become pregnant should practice effective birth control and contact her doctor immediately if pregnancy is suspected while taking Taro Letrozole.
Breast-feeding: It is not known if letrozole passes into breast milk. If you are a breast-feeding mother and are taking Taro Letrozole, it may affect your baby. Talk to your doctor about whether you should continue breast-feeding.
Children: The safety and effectiveness of Taro Letrozole have not been established for children. Children under 18 years of age should not use Taro Letrozole.
All material © 1996-2021 MediResource Inc. Terms and conditions of use. The contents herein are for informational purposes only. Always seek the advice of your physician or other qualified health providers with any questions you may have regarding a medical condition.
August 8, 2022
August 10, 2022
August 2, 2022